Upgrade to SI Premium - Free Trial

Mereo BioPharma (MREO)

0.27 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/17/26)

Latest Headlines

Form 8-K Mereo BioPharma Group For: Aug 18 August 19, 2026 7:53 AM - SEC Filing JPMorgan Downgrades Mereo BipPharma Group (MREO) to Underweight August 18, 2026 4:35 PM - StreetInsider Form SCHEDULE 13G/A Mereo BioPharma Group Filed by: EcoR1 Capital, LLC August 14, 2026 12:57 PM - SEC Filing Mereo BioPharma (MREO) Reports In-Line Q2 EPS August 11, 2026 9:33 AM - StreetInsider Form 10-Q Mereo BioPharma Group For: Jun 30 August 11, 2026 8:38 AM - SEC Filing Form 8-K Mereo BioPharma Group For: Aug 11 August 11, 2026 8:26 AM - SEC Filing Mereo BioPharma posts Q2 loss, signs alvelestat deal with Sentynl August 11, 2026 8:17 AM - StreetInsider Mereo BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Highlights August 11, 2026 8:15 AM - Globe NewsWire Form 8-K Mereo BioPharma Group For: Aug 11 August 11, 2026 8:07 AM - SEC Filing Mereo BioPharma strikes alvelestat licensing deal with Sentynl for U.S. rights August 11, 2026 8:01 AM - StreetInsider Mereo BioPharma licenses alvelestat to Sentynl for U.S. market August 11, 2026 8:00 AM - StreetInsider Sentynl Therapeutics and Mereo BioPharma Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD) August 11, 2026 8:00 AM - PR NewsWire Mereo BioPharma and Sentynl Therapeutics Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD) August 11, 2026 8:00 AM - StreetInsider Aura Biosciences adds former Day One CEO to its board July 8, 2026 7:01 AM - StreetInsider Aura Biosciences Announces Appointment of Jeremy Bender, Ph.D., M.B.A., to Board of Directors July 8, 2026 7:01 AM - Globe NewsWire Full Article List